Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc.

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

1. Introduction The coronavirus disease 2019 (COVID-19) is a major public health concern with a very important impact on the stability of the world [1]. The causative agent of this emerging virus has ...

Summary Illumina sequencing, a hallmark of second-generation sequencing technology, has revolutionized genomics research. This method employs a sophisticated reversible dye terminator technology to ...

We are keeping our fair value estimate on Illumina at $144 per share. In a sequencing industry that is expected to grow in the low double digits compounded annually during the next decade, we ...

HLA typing can be performed using numerous methods, including endpoint PCR, qPCR, Sanger sequencing, and next-generation sequencing (NGS).

Illumina. has been granted a patent for a method to prepare a library of template polynucleotides with common sequences at both ends, facilitating solid-phase nucleic acid amplification. The method ...

I want to process the sequencing data obtained by Croce et al in "Phage display profiling of CDR3β loops enables machine learning predictions of NY-ESO-1 specific TCRs" with TRUST4. They build large ...

Illumina, the leading producer of gene-sequencing machines, announced Sunday that it would sell Grail, a cancer test developer that it purchased for $7.1 billion in 2021.